Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using Platelet-Rich Plasma and Adipose-Derived Mesenchymal Stem Cells together can improve healing, including wound healing, bone regeneration, and hair growth.

Induced pluripotent stem cells are a major breakthrough in regenerative medicine.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

Minoxidil helps restore thymus size in 22q11.2 deletion syndrome.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Hydrogels are promising for treating complex diseases due to their adaptability and potential in drug delivery and tissue repair.

Plant-derived extracellular vesicles show promise for delivering drugs and treating diseases.

Targeting LGR4 may help treat cancer by reducing cancer stem cell traits and drug resistance.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

New drug delivery systems show promise in effectively treating pathological scars.

The skin microenvironment significantly affects hair growth and loss, offering potential treatment avenues.

The LTF gene may help predict and manage nonspecific orbital inflammation.

New hair regrowth therapies show promise but need more research.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

A new mouse model effectively mimics vitiligo for research and drug testing.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Minoxidil is more effective than Latanoprost for treating patchy alopecia areata.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

CD8 T cells need interferon gamma to cause Alopecia Areata.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.